On Apr. 13, 2016, the Parker Institute for Cancer Immunotherapy was created with a $250 million grant from the Parker Foundation, focused on accelerating progress in the breakthrough field that helps the immune system attack cancers.

Also collaborating were Memorial Sloan Kettering Cancer Center, Stanford Medicine, the University of California, San Francisco, the University of California, Los Angeles, and University of Pennsylvania.